SAN FRANCISCO (Thomson Financial) - Pfizer Inc. and FivePrime Therapeutics Inc. said Tuesday they have entered a collaborative research and license agreement focused on the treatment of certain cancers and diabetes.

Read More

Non-communicable diseases such as diabetes and hypertension are emerging as growing health problems among Palestinian refugees, said a United Nations report published Tuesday.

Read More

ANTIOCH – The Antioch Upper Grade School Diabetes fundraiser has come a long way since it started. Using what she knew about her students, gym teacher Beth Hook and the school’s physical education department revamped the school’s fundraiser, causing it to bring in more than quadruple the money of last year.

Read More

Diabetes and ED together deliver a double whammy to the heart, new studies suggest.

Read More

The question: Studies have shown people with diabetes face an increased risk for broken bones. Might this be related to the medication they take?

Read More

For three years, 9-year-old Cheyenne Dyarman has been trying to raise money for the American Diabetes Association.

Read More

For people with diabetes, high blood pressure poses a special threat, multiplying their risk of heart attacks, strokes and kidney problems.But a new study finds that even when people with diabetes show up in their doctor’s office with a high blood pressure reading, there’s only a 50-50 chance that each of them will get some sort of attention for it.

Read More

Phenomix Corporation announced that PHX1149, a dipeptidyl peptidase-4 (DPP-4) inhibitor, demonstrated positive results in a Phase 2b clinical trial for the treatment of Type 2 diabetes. The 12-week, double-blind, placebo-controlled clinical trial involving 422 randomized patients compared PHX1149 in once-daily oral doses of 200 milligrams and 400 milligrams to placebo.

Read More

The Diabetes Foundation of Mississippi will be sponsoring its annual Eagle Scramble Golf Tournament on May 19 at Canebrake Country Club.

Read More

Five Prime Therapeutics, Inc. and Pfizer Inc. (NYSE:PFE) today announced the initiation of a worldwide collaborative research and license agreement. The collaboration will focus on the discovery of antibody targets and novel therapeutic protein products to treat certain areas of cancer and diabetes. Under the collaboration, FivePrime will screen its comprehensive protein library in both …

Read More